Washington, DC - By the authority vested in me as President by the Constitution and the laws of the United States of America, and in order to maximize the impact of Federal Government resources to keep our communities safe, it is hereby ordered as follows:

Washington, DC - Deputy Attorney General Rosenstein Delivers Remarks at the America’s Health Insurance Plans' National Health Policy Conference:

Washington, DC - The Federal Trade Commission and the Federal Communications Commission today announced two upcoming events aimed at furthering the fight against illegal robocalls and caller ID spoofing. The agencies will co-host a Policy Forum later this month and a Technology Expo in April.

Washington, DC - Two providers of ambulance services have agreed to divest inter-facility air ambulance transport services in Hawaii to settle Federal Trade Commission charges that their proposed merger would likely harm competition among air ambulance transport services that transfer patients between medical facilities on different Hawaiian islands.

Washington, DC - The U.S. Food and Drug Administration today approved the Imugen Babesia microti Arrayed Fluorescent Immunoassay (AFIA), for the detection of antibodies to Babesia microti (B. microti) in human plasma samples, and the Imugen Babesia microti Nucleic Acid Test (NAT), for the detection of B. microti DNA in human whole blood samples. These tests are intended to be used as donor screening tests on samples from individual human donors, including volunteer donors of whole blood and blood components, as well as living organ and tissue donors.